09877.HK
Jenscare Scientific Co., Ltd.
HKSE · Healthcare · Medical - Specialties · CN
HKD 6.57
+0.77%Sep 23, 2026, 01:47 UTC
Jenscare Scientific said it is actively advancing the commercialization and clinical application of JensClip in mainland China and other markets, including pursuing CE MDR registration and overseas approvals.
Source:Sep 23, 2026, 01:47 UTC
China's National Medical Products Administration granted registration approval to Jenscare Scientific's self-developed transcatheter mitral valve clip and delivery system JensClip.
Source:Aug 31, 2026, 16:56 UTC
Jenscare Scientific Co., Ltd. reported interim results for the six months ended June 30, 2026, with revenue of RMB 64.13 million, up 377.7% year-over-year, and a narrowed net loss of RMB 48.69 million compared to RMB 170 million in the prior-year period.
Source:Jul 16, 2026, 04:29 UTC
Jenscare Scientific's LuX-Valve Plus system completed the first patient implantations in the FDA-approved pivotal clinical trial in the United States.
Source: